Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Short-term Investments (2009 - 2025)

Grifols' (GRFS) quarterly Short-term Investments came in at $41.9 million in Q4 2025, down 83.93% YoY from $260.7 million in Q4 2024, and down 83.93% on a QoQ basis from $260.7 million in Q4 2024.

Grifols (GRFS) Short-term Investments (2009 - 2025) Analysis & Trends

Grifols (GRFS) has 17 years of Short-term Investments data on file, last reported at $41.9 million in Q4 2025.

  • Quarterly Short-term Investments fell 83.93% year-over-year to $41.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41.9 million (down 83.93% YoY) and the FY2025 annual result came in at $41.9 million, down 83.93% from the prior year.
  • Short-term Investments retreated to $41.9 million in Q4 2025, from $260.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $260.7 million in Q4 2024 to a low of $3.7 million in Q4 2021.
  • A 5-year average of $75.3 million and a median of $41.9 million in 2025 frame the typical range for Short-term Investments.
  • Annual changes were most pronounced in 2022 — Short-term Investments surged 1102.62% — and 2025, when it tumbled 83.93%.
  • Tracing GRFS's Short-term Investments over 5 years: stood at $3.7 million in 2021, then surged by 1102.62% to $44.5 million in 2022, then tumbled by 42.89% to $25.4 million in 2023, then surged by 924.93% to $260.7 million in 2024, then plunged by 83.93% to $41.9 million in 2025.
  • The last three Short-term Investments figures came in at $41.9 million (Q4 2025), $260.7 million (Q4 2024), and $25.4 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Grifols 5.45 Bn 4.45 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 41.91 Mn
Dec 31, 2024 260.74 Mn
Dec 31, 2023 25.44 Mn
Dec 31, 2022 44.55 Mn
Dec 31, 2021 3.70 Mn
Dec 31, 2020 13.26 Mn
Sep 30, 2020 14.35 Mn
Mar 31, 2020 14.39 Mn
Dec 31, 2019 -610.45 Mn
Sep 30, 2019 3.08 Mn
Mar 31, 2019 202.58 Mn
Dec 31, 2018 61.60 Mn
Sep 30, 2018 59.78 Mn
Jun 30, 2018 -477.21 Mn
Mar 31, 2018 12.92 Mn
Dec 31, 2017 12.64 Mn
Jun 30, 2017 2.15 Bn
Dec 31, 2016 2.79 Mn
Sep 30, 2016 -443.57 Mn
Jun 30, 2016 363.82 Mn